Literature DB >> 1686582

Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells.

A Krishan1, A Sauerteig, J H Stein.   

Abstract

Cellular drug resistance to natural products is often due to the presence of an efflux pump which reduces intracellular drug content and chemosensitivity. A 170 kD cell surface resident P-glycoprotein is believed to act as the efflux pump. In the present report, we have compared three commercially available antibodies C-219, JSB-1, and mdr(Ab-1) for use in flow cytometric detection of P-glycoprotein positive cells. Our data show that C219 gives uniformly good results in a variety of murine and human tumor cell lines for detection of P-glycoprotein positive cells. We have also compared data of C219 stained cells analyzed in parallel on a flow cytometer equipped with a small laser (15 mW) and a large laser (5 watt) cell sorter. Data obtained on these two instruments are comparable. A staining protocol and data on dual staining of cells for DNA content by propidium iodide and P-glycoprotein expression after FITC labeling are also presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686582     DOI: 10.1002/cyto.990120807

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  8 in total

1.  Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells.

Authors:  K K Patterson; B S Beckman; D M Klotz; C M Mallia; J R Jeter
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  p-Glycoprotein expression as a predictor of breast cancer recurrence.

Authors:  S Gregorcyk; Y Kang; D Brandt; P Kolm; G Singer; R R Perry
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

3.  Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport.

Authors:  E Crivellato; L Candussio; A M Rosati; G Decorti; F B Klugmann; F Mallardi
Journal:  Histochem J       Date:  1999-10

4.  Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein.

Authors:  J M van Den Elsen; D A Kuntz; F J Hoedemaeker; D R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients.

Authors:  C Ramachandran; A Sauerteig; K S Sridhar; R J Thurer; A Krishan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients.

Authors:  Sawitree Chiampanichayakul; Songyot Anuchapreeda; Nuttapol Chruewkamlow; Kodchakorn Mahasongkram; Pattra Thanaratanakorn; Watchara Kasinrerk
Journal:  Int J Hematol       Date:  2010-08-26       Impact factor: 2.490

7.  Flow cytometric analysis of early steps in development of adriamycin resistance in a human gastric cancer cell line.

Authors:  S Tanaka; K Aizawa; N Katayanagi; O Tanaka
Journal:  Jpn J Cancer Res       Date:  1994-01

8.  Detection of low-level expression of P-glycoprotein in ACHN renal adenocarcinoma cells.

Authors:  S Kawamoto; T Deguchi; S Nezasa; S Yamada; M Okano; Y Kawada
Journal:  Jpn J Cancer Res       Date:  1996-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.